STOCK TITAN

Amneal to Virtually Participate at Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Amneal Pharmaceuticals (NYSE: AMRX) announced its participation in the Morgan Stanley Global Healthcare Conference on September 15, 2021, at 1:15 PM ET. Investors can access the live webcast through the company's Investor Relations page, with a replay available for 90 days afterward. Amneal is a fully-integrated pharmaceutical company based in Bridgewater, NJ, focusing on generic and specialty drug products, with a portfolio of approximately 250 product families.

Positive
  • Participation in the Morgan Stanley Global Healthcare Conference.
  • Access to live webcast and replay enhances investor communication.
Negative
  • None.

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today announced that members of management will participate at the Morgan Stanley Global Healthcare Conference held on September 15, 2021. The presentation will begin at 1:15 PM Eastern Time and a live webcast will be accessible through the Investor Relations section of the Company's website at https://investors.amneal.com. A replay of the webcast will be posted shortly after the call and will be available for 90 days following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. The Company has operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.

Amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system and endocrine disorders.

The Company also owns 65% of AvKARE. AvKARE provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, primarily focused on serving the Department of Defense and the Department of Veterans Affairs. AvKARE is also a packager and wholesale distributor of pharmaceuticals and vitamins to its retail and institutional customers who are located throughout the United States focused primarily on offering 340b-qualified entities products to provide consistency in care and pricing. For more information, visit www.amneal.com.

Tony DiMeo

Senior Director, Investor Relations

Anthony.DiMeo@amneal.com

Source: Amneal Pharmaceuticals, Inc.

FAQ

When is Amneal Pharmaceuticals participating in the Morgan Stanley Global Healthcare Conference?

Amneal Pharmaceuticals will participate in the Morgan Stanley Global Healthcare Conference on September 15, 2021.

What time will Amneal's presentation at the conference start?

Amneal's presentation at the Morgan Stanley Global Healthcare Conference is scheduled to begin at 1:15 PM Eastern Time.

How can I access the webcast of Amneal's presentation?

The webcast of Amneal's presentation can be accessed through their Investor Relations page at https://investors.amneal.com.

Will a replay of the presentation be available?

Yes, a replay of the presentation will be available for 90 days after the event.

What are the business operations of Amneal Pharmaceuticals?

Amneal Pharmaceuticals focuses on the development, manufacturing, and distribution of generic and specialty drug products.

Amneal Pharmaceuticals, Inc.

NASDAQ:AMRX

AMRX Rankings

AMRX Latest News

AMRX Stock Data

2.40B
135.66M
52.19%
46.48%
1.45%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
Bridgewater